Related Experiment Video

Updated: Sep 23, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

[Our experience with cedax (ceftibuten) in the obstetrical and gynecological practice]

L Lazarov, N Lazarov, G Lazarova

    Akusherstvo I Ginekologiia
    |July 16, 2003
    PubMed

    Insights

    Cedax, an oral cephalosporin, is effective for treating asymptomatic bacteriuria in pregnant women. This study found it a preferred option due to ease of use and no reported side effects.

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Obstetrics

    Background:

    • Asymptomatic bacteriuria is common in pregnancy and can lead to complications.
    • Third-generation cephalosporins are frequently used for urinary tract infections.

    Purpose of the Study:

    • To compare the efficacy and safety of Cedax (ceftibuten) with other third-generation cephalosporins.
    • To evaluate Cedax as a treatment option for asymptomatic bacteriuria in pregnant women.

    Main Methods:

    • A comparative study involving 40 pregnant women with asymptomatic bacteriuria.
    • Treatment with Cedax versus other third-generation cephalosporins.

    Main Results:

    • Cedax demonstrated a wide spectrum of antibacterial activity.
    • No side effects were reported with Cedax treatment.

    Conclusions:

    • Cedax is a preferred antibacterial drug for treating asymptomatic bacteriuria in pregnancy.
    • Its easy administration and safety profile make it advantageous.

    Related Concept Videos

    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

    Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
    Urine Studies II: Urine Culture and Sensitivity Test01:26

    Urine Studies II: Urine Culture and Sensitivity Test

    A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

    A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
    Urinary Tract Infection IV: Nursing Management01:17

    Urinary Tract Infection IV: Nursing Management

    In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...